MedTrace Logo

Thromboelastometry Prediction Utility for Risk of Abortion

NCT03548701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2020-06-01

No results posted yet for this study

Summary

This study will use thromboelastometry in ED patients with vaginal bleeding, as well as healthy pregnant controls, to determine if abnormal results are associated with the presence of vaginal bleeding as well as later complications during pregnancy.

Conditions

  • Pregnancy Trimester, First
  • Abortion, Threatened

Interventions

DIAGNOSTIC_TEST

Thromboelastometry testing

Thromboelastometry testing - a form of testing in whole blood for coagulation abnormalities

Sponsors & Collaborators

Principal Investigators

  • Patrick J Maher, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-04
Primary Completion
2019-05-15
Completion
2019-05-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03548701 on ClinicalTrials.gov